濕性傷口敷料市場－全球產業規模、佔有率、趨勢、機會及預測：按產品、應用、最終用戶、地區和競爭對手分類，2021-2031年

全球濕性傷口敷料市場預計將從 2025 年的 57.5 億美元成長到 2031 年的 91.9 億美元，複合年成長率為 8.13%。

與傳統乾紗布不同，這些專用醫療用品可透過維持濕潤環境來促進組織修復並防止乾燥。市場成長的主要驅動力是全球慢性疾病負擔的加重，尤其是血管疾病和糖尿病，這些疾病導致需要高級護理的複雜潰瘍病例不斷增加。此外，全球老年人口的成長和外科手術數量的增加也推動了對有效術後傷口管理解決方案的需求，旨在最大限度地縮短恢復時間。

然而，這些先進的治療方法價格昂貴，在預算緊張的醫療體系中往往面臨嚴格的報銷政策，阻礙了其廣泛應用。儘管患者對慢性傷口管理的需求日益成長，但這項經濟障礙仍然是一項巨大的挑戰。國際糖尿病聯盟（IDF）估計，到2024年，全球將有約5.89億成年人患有糖尿病，凸顯了開發經濟有效的創傷護理策略以應對糖尿病足潰瘍及其併發症日益增多的迫切需求。

市場促進因素

慢性傷口和難癒合傷口（尤其是糖尿病足潰瘍）的日益普遍，是全球濕性傷口敷料市場的主要促進因素。這些複雜的傷口需要長期控制滲出液並維持濕潤環境以促進上皮化，因此，使用親水膠體和泡棉敷料等先進敷料而非傳統紗布至關重要。慢性疾病的負擔進一步凸顯了這個臨床需求。根據美國國立衛生研究院 (NIH) 2025 年 7 月發布的報告《人類傷口及其負擔：2025 年估計值》，美國約有 1,050 萬名聯邦醫療保險受益人患有慢性傷口，這造成了對治療方案的巨大需求。

同時，全球老年人口的快速成長正顯著影響市場需求。老年患者的生理變化會延緩傷口癒合，與老齡化相關的皮膚血管減少也會增加壓瘡的風險。世界衛生組織（世衛組織）於2025年2月發布的最新報告《老化與健康》指出，2024年全球平均壽命將達到73.3歲，將推動人口結構的變化，預計2030年，60歲以上人口將達到14億。這項需求也反映在產業績效上。康維特集團在2025年2月發布的《截至2024年12月31日止年度財務業績》中報告稱，其創傷護理部門的有機收入成長了7.4%，這主要得益於抗菌和泡沫技術的進步。

市場挑戰

全球濕性傷口敷料市場成長的主要障礙在於先進治療方法的高成本以及預算緊張的醫療體系中嚴格的報銷政策。儘管濕性傷口敷料相比傳統乾紗布具有更優的臨床療效，但其高昂的價格在注重成本的市場中卻構成了一大障礙。醫療機構和保險公司往往在沒有充分的財務理由的情況下，不願意核准使用如此昂貴的醫療用品，導致人們必須依賴更便宜但療效較差的替代方案。這種財務上的阻礙限制了先進產品的普及，尤其是在嚴格財務監管的公共醫療領域。

因此，治療慢性疾病的經濟負擔反而限制了針對慢性疾病管理的解決方案的普及。根據創傷治療）預測，到2025年，慢性傷口的管理預計將每年耗費美國聯邦醫療保險（Medicare）約225億美元。如此巨大的經濟負擔迫使支付方採用嚴格的報銷標準，這反過來又阻礙了高價濕敷料技術的市場滲透，並減緩了整個行業的擴張。

市場趨勢

市場正經歷著一場決定性的轉變，即轉向具有生物活性和抗菌特性的混合敷料，這類敷料能夠主動促進組織修復，而不僅僅提供被動的屏障功能。這項轉變的驅動力源自於臨床上解決複雜慢性潰瘍生物膜形成和癒合停滯問題的需求，促使製造商將生物細胞結構和銀技術等活化劑直接融入敷料基質中。對這些高效治療方案的需求正在顯著改變產業的收入結構。根據史密斯醫療（Smith+Nephew）於2025年2月發布的“2024會計年度第四季度及全年業績報告”，其高級傷口生物活性產品業務部門實現了20.3%的基礎收入成長，這主要得益於皮膚替代物和感染控制產品的強勁市場需求。

同時，隨著主要相關人員將業務活動與環境管治相結合，努力減少醫療廢棄物，人們對可生物分解和永續的創傷護理解決方案的興趣日益濃厚。這一趨勢正迫使企業重新設計其製造生態系統，優先考慮在地化生產和可再生能源的整合，以降低高能耗泡沫和矽膠材料生產過程中的碳排放強度。例如，根據2025年6月一篇題為《Mornlycke Healthcare 為提升永續製造能力而進行史上最大規模投資，並在美國緬因州擴建工廠》的報導，該公司宣布投資1.15億歐元，利用風能和太陽能等再生能源來源擴建其製造工廠，這便是向永續基礎設施戰略轉變的一個例證。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球濕性傷口敷料市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 產品類別（泡棉敷料、親水膠體敷料、膜敷料、藻酸鹽敷料、水凝膠敷料、膠原蛋白敷料、其他）
  • 依應用領域（急性傷口、慢性傷口）
  • 依最終使用者（醫院、專科診所、居家醫療等）分類
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美濕性傷口敷料市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲濕敷料市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區濕性傷口敷料市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲濕性傷口敷料市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲濕敷料市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章 全球濕性傷口敷料市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Coloplast A/S
• Medline Industries, Inc.
• Smith & Nephew PLC
• Convatec, Inc.
• Systagenix pvt ltd
• Derma Sciences, Inc.
• Cardinal Health Inc.
• Acelity LPInc
• 3M Company
• B. Braun Medical Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Moist Wound Dressings Market is projected to expand from USD 5.75 Billion in 2025 to USD 9.19 Billion by 2031, registering a CAGR of 8.13%. Unlike traditional dry gauze, these specialized medical supplies maintain a hydrated environment to accelerate tissue repair and prevent desiccation. The market is fundamentally driven by the rising global burden of chronic diseases, specifically vascular disorders and diabetes, which result in a higher incidence of complex ulcers necessitating advanced care. Furthermore, the expanding geriatric population and increasing volume of surgical procedures worldwide sustain the demand for effective postoperative wound management solutions aimed at minimizing recovery times.

However, widespread adoption is hindered by the high costs associated with these advanced therapies, which frequently encounter strict reimbursement policies within budget-constrained healthcare systems. Despite the escalating patient need for chronic wound management, this financial hurdle remains a significant obstacle. According to the International Diabetes Federation, an estimated 589 million adults worldwide were living with diabetes in 2024, underscoring the critical necessity for cost-effective wound care strategies to manage the associated rise in diabetic foot ulcers and complications.

Market Driver

The escalating prevalence of chronic and non-healing wounds, particularly diabetic foot ulcers, serves as the primary catalyst for the global moist wound dressings market. These complex wounds require prolonged exudate management and moisture balance to facilitate re-epithelialization, necessitating advanced dressings like hydrocolloids and foams rather than traditional gauze. This clinical necessity is underscored by the burden of chronic conditions; according to the National Institutes of Health's 'Human Wound and Its Burden: Updated 2025 Compendium of Estimates,' published in July 2025, chronic wounds affect approximately 10.5 million Medicare beneficiaries in the United States, creating substantial demand for therapeutic solutions.

Simultaneously, the rapid expansion of the global geriatric population critically shapes market demand, as physiological changes in elderly patients delay healing and aging skin's reduced vascularity increases susceptibility to pressure ulcers. According to the World Health Organization's 'Ageing and Health' update from February 2025, global life expectancy reached 73.3 years in 2024, driving a demographic shift where the population aged 60 and older is projected to reach 1.4 billion by 2030. This demand is reflected in industry performance; Convatec Group Plc reported in their 'Annual Results for the year ended 31 December 2024,' released in February 2025, that their Advanced Wound Care division achieved organic revenue growth of 7.4%, driven by antimicrobial and foam technologies.

Market Challenge

The primary factor hampering the growth of the Global Moist Wound Dressings Market is the high cost of advanced therapies coupled with strict reimbursement policies in budget-constrained healthcare systems. While moist wound dressings offer superior clinical outcomes compared to traditional dry gauze, their premium pricing creates a substantial barrier in markets where cost containment is a priority. Healthcare providers and insurers often hesitate to authorize these expensive supplies without irrefutable economic justification, leading to a reliance on cheaper, less effective alternatives. This financial friction limits the volume of advanced products utilized, particularly in public health sectors facing tight fiscal scrutiny.

Consequently, the economic burden of treating chronic conditions paradoxically restricts the adoption of the very solutions designed to manage them. According to the Wound Healing Society, in 2025, the management of chronic wounds cost the Medicare system an estimated 22.5 billion dollars annually. This immense financial strain compels payers to enforce rigorous reimbursement criteria, thereby reducing the market penetration of higher-priced moist dressing technologies and slowing overall industry expansion.

Market Trends

The market is witnessing a decisive shift toward bioactive and antimicrobial hybrid dressings that actively stimulate tissue repair rather than merely serving as a passive barrier. This transition is fueled by the clinical necessity to combat biofilm formation and stalled healing trajectories in complex chronic ulcers, prompting manufacturers to integrate active agents, such as living cell constructs and silver technologies, directly into dressing matrices. This demand for high-efficacy therapeutic solutions is significantly reshaping industry revenue streams; according to Smith+Nephew's 'Fourth Quarter and Full Year 2024 Results' from February 2025, the Advanced Wound Bioactives business unit delivered underlying revenue growth of 20.3%, driven by the strong adoption of skin substitutes and infection management products.

Concurrently, there is an intensifying focus on biodegradable and sustainable wound care solutions as major stakeholders align operational footprints with environmental governance to mitigate medical waste. This trend compels companies to redesign manufacturing ecosystems, prioritizing localized production and renewable energy integration to lower the carbon intensity of producing energy-intensive foam and silicone materials. Highlighting this strategic pivot toward sustainable infrastructure, according to the article 'Molnlycke Health Care makes record investment to increase global manufacturing capacity with expansion in Maine, USA' from June 2025, Molnlycke Health Care announced a €115 million investment to expand a manufacturing facility designed to utilize renewable energy sources such as wind and solar power.

Key Market Players

• Coloplast A/S
• Medline Industries, Inc.
• Smith & Nephew PLC
• Convatec, Inc.
• Systagenix pvt ltd
• Derma Sciences, Inc.
• Cardinal Health Inc.
• Acelity L.P.Inc
• 3M Company
• B. Braun Medical Inc.

Report Scope

In this report, the Global Moist Wound Dressings Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Moist Wound Dressings Market, By Product

• Foam Dressings
• Hydrocolloid Dressings
• Film Dressings
• Alginate Dressings
• Hydrogel Dressings
• Collagen Dressings
• Other

Moist Wound Dressings Market, By Application

• Acute Wounds
• Chronic Wounds

Moist Wound Dressings Market, By End User

• Hospitals
• Specialty Clinics
• Home Healthcare
• Others

Moist Wound Dressings Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Moist Wound Dressings Market.

Available Customizations:

Global Moist Wound Dressings Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Moist Wound Dressings Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Foam Dressings, Hydrocolloid Dressings, Film Dressings, Alginate Dressings, Hydrogel Dressings, Collagen Dressings, Other)
  • 5.2.2. By Application (Acute Wounds, Chronic Wounds)
  • 5.2.3. By End User (Hospitals, Specialty Clinics, Home Healthcare, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Moist Wound Dressings Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Moist Wound Dressings Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Moist Wound Dressings Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Moist Wound Dressings Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Moist Wound Dressings Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Moist Wound Dressings Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. France Moist Wound Dressings Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Moist Wound Dressings Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Moist Wound Dressings Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Moist Wound Dressings Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia Pacific Moist Wound Dressings Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Moist Wound Dressings Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Moist Wound Dressings Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Moist Wound Dressings Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Moist Wound Dressings Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Moist Wound Dressings Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. Middle East & Africa Moist Wound Dressings Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Moist Wound Dressings Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Moist Wound Dressings Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Moist Wound Dressings Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. South America Moist Wound Dressings Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Moist Wound Dressings Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Moist Wound Dressings Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Moist Wound Dressings Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Moist Wound Dressings Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Coloplast A/S
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Medline Industries, Inc.
• 15.3. Smith & Nephew PLC
• 15.4. Convatec, Inc.
• 15.5. Systagenix pvt ltd
• 15.6. Derma Sciences, Inc.
• 15.7. Cardinal Health Inc.
• 15.8. Acelity L.P.Inc
• 15.9. 3M Company
• 15.10. B. Braun Medical Inc.

16. Strategic Recommendations

17. About Us & Disclaimer